ProgressPotentialAndPossibilities

Short from @Progress, Potential, and Possibilities - https://www.youtube.com/watch?v=lpix77D-Rwg&t=1s

Short from @Progress, Potential, and Possibilities - https://www.youtube.com/watch?v=xoHQo4iYRAA&t=1s

Short from @Progress, Potential, and Possibilities - https://www.youtube.com/watch?v=lMIWf6CDZPA&t=1s

Short from @Progress, Potential, and Possibilities - https://www.youtube.com/watch?v=dTrve_Fdej8

Dr. Amy Proal, Ph.D. serves as President & CEO of the PolyBio Research Foundation (https://polybio.org/), and Chief Scientific Officer of the Long Covid Research Initiative (LCRI - https://lc19.org/). In her work with PolyBio Research Foundation and the LCRI, Dr. Proal conceptualizes and coordinates large-scale collaborative research projects among research teams studying infection-associated chronic conditions such as Long Covid, Myalgic Encephalomyelitis / Chronic Fatigue Syndrome (ME/CFS) and Long Lyme. Dr. Proal has written multiple review articles that delineate core biological drivers of both the Long Covid and ME/CFS disease processes. She is a regular speaker at infection-associated chronic disease conferences including IACFS/ME, Lyme Mind and The International Congress on Autoimmunity. Dr. Proal holds a Bachelors of Science in biology from Georgetown University and a Ph.D. in microbiology from Murdoch University in Australia. Her work examines the molecular mechanisms by which viral, bacterial, and fungal pathogens dysregulate human gene expression, immunity, and metabolism, and how dysbiosis of the human microbiome, and/or the human virome, can contribute to chronic inflammatory disease processes. As a member of the research team at Autoimmunity Research Foundation, Dr. Proal has authored papers and written book chapters for organizations like the J. Craig Venter Institute and The Autoimmunity Network, and lectured at the NIH and numerous USA/international conferences.

Dr. Sarita A. Mohanty, MD, MPH, MBA (https://www.thescanfoundation.org/about/board-of-directors/sarita-a-mohanty/), serves as the President and Chief Executive Officer of The SCAN Foundation, one of the largest foundations in the United States focused on improving the quality of health and life for older adults. Its mission is to advance a coordinated and easily navigated system of high-quality services for older adults that preserve dignity and independence. The SCAN Foundation was created as an independent charitable organization in April 2008 through a $205 Million one-time contribution from the not-for-profit SCAN Health Plan, a not-for-profit, Medicare Advantage based in Long Beach, California. Previously, Dr. Mohanty served as the Vice President of Care Coordination for Medicaid and Vulnerable Populations at Kaiser Permanente; Assistant Professor of Medicine at USC; Chief Medical Officer of COPE Health Solutions, a health care management consulting company; and Senior Medical Director at L.A. Care, the largest U.S. public health plan. Dr. Mohanty completed her Internal Medicine residency at Beth Israel Deaconess Medical Center and research fellowship at Harvard Medical School. She earned her MD from Boston University, MPH from Harvard University, and MBA from UCLA. She completed undergraduate work at UC Berkeley. She currently is an Associate Professor at the Kaiser Permanente Bernard J. Tyson School of Medicine and is a practicing internal medicine physician with Kaiser Permanente.

Dr. Ava Cadell, Ph.D., Ed.D (https://www.avacadell.com/) is an actress, an accomplished author of ten books, a producer, a therapist and a global speaker on wide range of issues of human sexuality, as well as founder of Loveology University (https://www.loveuniv.com/) and the personal brand "Sexual Empowerment". Dr. Cadell earned a doctorate in human behavior from Newport University (CA) and a doctorate of education in human sexuality from the Institute for Advanced Study of Human Sexuality in San Francisco. She is also a certified hypnotherapist, certified American Association of Sexuality Educators, Counselors, and Therapists (AASECT) sex counselor, on the advisory board of the American College of Sexologists International, hosts a popular sex news blog at www.Sexpert.com and is a continuing education provider for the California Board of Behavioral Sciences and California Board of Nursing. Through her private practice in L.A., Dr. Cadell counsels some of Hollywood's elite on personal issues that range from anger management, fear of intimacy, communication problems, performance anxiety, infidelity, love and sex addiction, lack of desire, power struggles to parental concerns. A highly sought after speaker, Dr. Cadell has traveled to four continents, motivating Fortune 500 business people, religious organizations, medical institutes, women's groups and college students to embrace the power of love and create magical relationships. Dr. Cadell's filmography is extensive with appearances in movies like Commando, History of the World, Part 1, Smokey and the Bandit Part 3, as well as having appeared on hundreds of TV shows including The Doctors, LA Shrinks, Kendra on Top, Cathouse: The Series, as well as a variety of programs for MTV, VH1, Discovery, Lifetime, TLC, "E" and A&E. Dr. Cadell recently opened a 45-Acre Loveology Retreat ( https://www.loveologyretreat.com/ ); a visually stunning and awe-inspiring “Magical Property” in Maricopa, CA, about a two hour drive north of Los Angeles, whose activities include Yoga & Meditation, Hiking, Holistic Services, Stargazing, Filming & Photo Locations, and Corporate Team Building.

Short from @Progress, Potential, and Possibilities - https://www.youtube.com/watch?v=4d2SC3MFTBI&t=1s

Short from @Progress, Potential, and Possibilities - https://www.youtube.com/watch?v=sXn2SKkXcfY&t=1s

Short from @Progress, Potential, and Possibilities - https://www.youtube.com/watch?v=O2Ebbu2WhK0&t=1s

Short from @Progress, Potential, and Possibilities - https://www.youtube.com/watch?v=V8kayRhwsHI&t=1s

Short from @Progress, Potential, and Possibilities - https://www.youtube.com/watch?v=n9H6uhvOI60&t=1s

Professor Dr. Andrea B. Maier, MD, Ph.D., is the Oon Chiew Seng Professor in Medicine, Healthy Ageing and Dementia Research, and Co-Director of the Centre for Healthy Longevity, at the National University Of Singapore (https://discovery.nus.edu.sg/19564-andrea-britta-maier). Professor Maier also holds professorship appointments at VU University Medical Centre - https://research.vu.nl/en/persons/andrea-maier , Amsterdam, Netherlands, and University of Melbourne (https://findanexpert.unimelb.edu.au/profile/773728-andrea-maier), Australia, as well as is Director of Medicine and Community Care at the Royal Melbourne Hospital, Australia. Professor Maier is also the President of the Australia and New Zealand Society for Sarcopenia and Frailty Research, as well as Founding President of the Healthy Longevity Medicine Society - https://hlms.co/ . A Fellow of the Royal Australasian College of Physicians (FRACP), Professor Maier graduated in Medicine (MD) 2003 from the University of Lübeck (Germany), was registered 2009 in The Netherlands as Specialist in Internal Medicine-Geriatrics and was appointed Full Professor of Gerontology at Vrije Universiteit Amsterdam (The Netherlands) in 2013 where she was the head of Geriatrics at the Vrije Universiteit Medical Center from 2012 to 2016. From 2016 to early 2021, Professor Maier served as Divisional Director of Medicine and Community Care at the Royal Melbourne Hospital, Australia, and as Professor of Medicine and Aged Care at the University of Melbourne, Australia. Professor Maier’s research focuses on unraveling the mechanisms of ageing and age-related diseases and during the last 10 years she has conducted multiple international observational cohort studies and intervention trials and has published more than 350 peer-reviewed articles. She is a frequent guest on radio and television programs to disseminate aging research and an invited member of several international academic and health policy committees, including the WHO. She also serves as selected Member of The Royal Holland Society of Sciences and Humanities.

Ambassador Nancy G. Brinker (https://nancybrinker.com/) is Founder of the Susan G. Komen Breast Cancer Foundation (https://www.komen.org/) and Co-Founder of the Promise Fund of Florida (https://www.promisefundofflorida.org/). Amb. Brinker is a three-time Ambassador and New York Times best-selling author who is regarded as the leader of the global breast cancer movement. Her journey began with a promise to her dying sister, Susan G. Komen, that she would do everything possible to end the shame, pain, fear, and hopelessness caused by this disease. In one generation, the organization that bears Susan’s name has changed the world. In 2009, President Barack Obama honored Amb. Brinker with the Presidential Medal of Freedom, the nation’s highest civilian honor, for this work. The same year, she was named Goodwill Ambassador for Cancer Control for the United Nations’ World Health Organization, where she continued her mission to put cancer control at the top of the world health agenda. In 2010, Amb. Brinker released her New York Times best-selling memoir “Promise Me - How a Sister's Love Launched the Global Movement to End Breast Cancer” (https://www.amazon.com/gp/product/0307718123?ie=UTF8&tag=nangbri-20&linkCode=as2&camp=1789&creative=9325&creativeASIN=0307718123), an inspirational story of her transformation from bereaved sister to the undisputed leader of the ongoing international movement to end breast cancer. From 2001-2003, Amb. Brinker served as U.S. Ambassador to the Republic of Hungary and served as U.S. Chief of Protocol from 2007-2009. Amb. Brinker is also the host of a weekly show on Newsmax TV which features news makers, corporate leaders, and high-profile cultural thought leaders. In 2018, Amb. Brinker spearheaded the creation of the Promise Fund of Florida, a nonprofit organization whose mission is to improve the outcomes and reduce deaths from breast and cervical cancers in Palm Beach County, where 80,000 women reside with no insurance and no medical home. The Promise Fund is utilizing partnerships, navigation, policy changes, and community awareness to build a model of care to be replicated throughout the country. The Promise Fund provides necessary education and screenings to prevent late-stage diagnosis and improve community health for under-resourced women confronting health disparities.

Dr. Doris A. Taylor, Ph.D. is Chief Executive Officer of Organamet Bio Inc. (https://organametbio.com/) an early phase start-up committed to saving lives and reducing the cost of healthcare for those with heart disease. Organamet has a goal is to make personalized bio-engineered human hearts, available to all who need them, within 5 years, increasing availability and access to hearts, decreasing or eliminating need for immunosuppression, reducing total lifetime transplant costs, and improving quality of life. Dr. Taylor was previously the Director, Regenerative Medicine Research and Director, Center for Cell and Organ Biotechnology, at the Texas Heart Institute in Houston, Texas, where she worked on the integration of regenerative medicine and tissue engineering. Dr. Taylor has a Ph.D. in Pharmacology from UT Southwestern Medical Center, Dallas, Texas. She did her post-doctoral studies at Albert Einstein College of Medicine in the Bronx, New York, where she first worked with tissue engineering, growing heart muscle cells in the laboratory. Dr. Taylor was on the faculty of Duke University from 1991 to 2007, and then moved to University of Minnesota, where in 2008 her team published a landmark paper in Nature Medicine where they created new beating rat hearts using a combination of tissue engineering processes, first stripping the dead dying cells away from an existing heart (in a process called "de-cellularization") leaving behind the hearts extracellular matrix and then re-seeding the matrix by injecting new young rat stem cells. Dr. Taylor is also Co-Founder and original Board member of Miromatrix Medical Inc. Dr. Taylor's work has been published in Nature Medicine, Circulation Research, The Journal of Molecular Biology, The Journal of Biochemistry, Journal of the American College of Cardiology (JACC), Journal of the American Medical Association (JAMA), and other top-tier scientific journals. She holds a number of invention disclosures, patent applications and patents and is the founder of multiple companies dedicated to cardiovascular repair technologies. She is a member of the Society for Women's Health Research (SWHR) Cardiovascular Working Group and the Organization for the Study of Sex Differences (OSSD). Other professional affiliations include the American Association for the Advancement of Science (AAAS), the American Heart Association (AHA), and the Federation of American Societies for Experimental Biology (FASEB), among others. She recently served on the Executive Committee for the Alliance for Regenerative Medicine (ARM). Dr. Taylor has been recognized by the AHA for Top 10 Research Advances. Her work has been recognized and featured by 60 Minutes, NPR, CNN, The New York Times, The Wall Street Journal, BBC Horizon, BBC News Health, ABC News, NBC News, CBS News, Associated Press, National Public Radio, Good Morning America, Forbes, the Oprah Winfrey Show, NOVA Science Now, Discovery Channel’s Through the Worm Hole with Morgan Freeman, Science Channel’s Stem Cell Universe with Stephen Hawking, and numerous other worldwide media outlets.

Dan Harary (https://www.danhararyauthor.com/) is an author, entertainment industry publicist, drummer and former stand-up comic. While best known for his 50 years of work in Hollywood as an entertainment industry publicist and owner of the boutique Asbury PR Agency (https://asburypr.com/) in Beverly Hills, Dan is also the author of four books: Flirting With Fame - A Hollywood Publicist Recalls 50 Years of Celebrity Close Encounters, After They Came, Inside The Cutting Room: A Backstage Look at New York's Last Rock 'n' Roll Mecca and Carrots: True Confessions of a Hollywood Sex Addict (https://www.amazon.com/gp/product/1629339652/ref=dbs_a_def_rwt_bibl_vppi_i2) A native of Ocean Township, NJ, Dan worked as Stage Manager at the legendary Sunshine Inn concert hall in Asbury Park in the early 1970’s, with such now iconic musicians as Bruce Springsteen, KISS and Fleetwood Mac. Dan graduated Boston University, with a Bachelor of Science Degree in Communications, having studied TV production, advertising, marketing and journalism – ironically, every type of communications EXCEPT public relations, worked at Columbia Pictures/New York and relocated to Los Angeles in 1980. Dan's first post in Hollywood was as an Assistant at the American Film Institute; he then landed in-house PR positions with: the Playboy Channel (where he handled all PR and Program Information for the TV programs, movies and specials including events which were held at Hugh Hefner’s Playboy Mansion), Columbia Pictures Television, working closely with Brooke Shields on the Blue Lagoon, as well as being in charge of PR for the syndicated TV series “The New Gidget,” “What’s Happening Now!” and “The Real Ghostbusters”, and two top Hollywood entertainment PR agencies (Solters/Roskin/Friedman and The Lippin Group), before launching his own PR Agency in 1996 where he specializes in the representation of clients and individuals working across all areas of the entertainment and leisure industries.

Dr. Andrew Hebbeler, Ph.D., is Principal Assistant Director for Health and Life Sciences, Office of Science and Technology Policy at The White House (https://www.whitehouse.gov/ostp/ostps-teams/health-and-life-sciences/), and has extensive foreign affairs, national security, global health, and science and technology (S&T) policy experience. Most recently, Dr. Hebbeler was Senior Director and Lead Scientist for Global Biological Policy and Programs at the non-profit Nuclear Threat Initiative and previous to that served in leadership positions at the State Department's offices of Science and Technology Cooperation (OES/STC), the Science and Technology Adviser to the Secretary of State (E/STAS), and Cooperative Threat Reduction (ISN/CTR). From 2013-2015, Dr. Hebbeler was Assistant Director for Biological and Chemical Threats at the Obama White House Office of Science and Technology Policy where he oversaw American S&T efforts to combat infectious disease and chemical weapon threats. Prior to his White House position, Dr. Hebbeler led the State Department's Biosecurity Engagement Program, a $40M program that prevents terrorist access to potentially dangerous biological materials and dual-use infrastructure and expertise, while supporting efforts to combat infectious disease and enhance public and animal health worldwide. Dr. Hebbeler received his Bachelor’s degree in biology and philosophy from Thomas More College, and completed his doctoral work in Molecular Microbiology and Immunology in the laboratory of C. David Pauza at the University of Maryland, Baltimore where he focused on understanding an unconventional lymphocyte population that is important during immune responses to infectious disease and cancer. Before joining the State Department, Dr. Hebbeler was a postdoctoral fellow in the laboratory of Warner C. Greene at The J. David Gladstone Institutes in San Francisco, California.

Bill Taranto is President of the Global Health Innovation Fund at Merck (https://www.merckghifund.com/taranto.html) and founding partner since inception in 2010. Merck Global Health Innovation Fund (Merck GHI) is a corporate venture capital group utilizing a healthcare ecosystem strategy, investing globally in platform companies with proven technologies or business models where Merck's expertise can accelerate revenue growth and enhance value creation to ultimately develop integrated healthcare solutions. Merck GHI has $500M under management per an evergreen model and invests broadly in the domain of digital health, and other segments, and has made over 60 investments in portfolio companies, and has over 20 exits. They invest across the segments of Therapy Planning, Care Management, Health Analytics & AI, eClinical Trials and enabling technologies. Bill has more than 30 years of health care experience including over 20 years of healthcare investing. In addition to his experience in venture investing, Bill has more than a decade of management operations experience. Bill is also the chairman of the Merck Innovative Ventures Board, a group that manages the identification and funding of portfolio businesses; and is also Chairman of the GHI Fund LLC Management Board. Prior to joining Merck, Bill spent 18 years at Johnson & Johnson in various venture capital, marketing, sales and business development roles. Before J&J, Bill spent eight years in investment banking. He has a Bachelor of Business Administration from St. Bonaventure University.

Lisa R. Sanders is the Director of Science and Technology for Special Operations Forces, Acquisition, Technology & Logistics (SOF AT&L), U.S. Special Operations Command (USSOCOM - https://www.socom.mil/), located at MacDill Air Force Base, Florida, where she is responsible for all research and development funded activities - https://www.socom.mil/SOF-ATL/Pages/eSOF_cap_of_interest.aspx Ms. Sanders has over 30 years of civilian Federal service. She entered Federal Service as an Electronics Engineer at Naval Avionics Center in Indianapolis, Indiana where she served in quality engineering, production engineering and program management. In 1996, she transferred to Naval Air Warfare Center and Naval Air Systems Command (NAVAIR), Patuxent River, Maryland, serving as an Electronics Engineer and Program Manager for the E-2C Hawkeye aircraft. In 2003, she assumed responsibility for the production and modification of the CV-22 (a Vertical takeoff and landing aircraft). During her time at NAVAIR, she managed one of the first Multi-Year Procurements, and executed the modification and delivery of CV-22 production and developmental test aircraft. Ms. Sanders transferred to USSOCOM in 2005, where she retained responsibility for CV-22 production and worked as the Systems Acquisition Manager for the C-130 program in Program Executive Office Fixed Wing managing all C-130 projects across the Special Operations Forces inventory. In 2010, Ms. Sanders was promoted to position of Deputy Director for the Science and Technology Directorate; and in 2011, was assigned to the position of Director, Science & Technology. In 2014, Ms. Sanders left USSOCOM to attend the Defense Acquisition University Senior Service College Fellowship in Aberdeen, Maryland. She graduated in 2015, and was assigned to Headquarters, Air Force serving as the chair of the Air Force Capability Development Working Group. In 2016, she was selected as a Defense Intelligence Senior Leader. Ms. Sanders has her Bachelor of Science in Mechanical Engineering, from GMI Engineering & Management Institute (Kettering University), Flint, MI, her Master’s in Business Administration, from St. Leo University, St. Leo, FL, and did a Senior Service College Fellowship, Aberdeen MD in Senior Professional Military Education.

Dr. Greg Lieberman, Ph.D. (https://www.arl.army.mil/arl25/meet-arl.php?gregory_lieberman) is a Neuroscientist, and Lead, Optimizing Human-System Performance, at the U.S. Army Combat Capabilities Development Command, Army Research Laboratory (DEVCOM ARL). DEVCOM ARL, as an integral part of the Army Futures Command, is the Army’s foundational research laboratory focused on operationalizing science to ensure overmatch in any future conflict. DEVCOM ARL shapes future concepts with scientific research and knowledge and delivers technology for modernization solutions to win in the future operating environment. With a Ph.D. from the University of Vermont in Neuroscience, a Postdoctoral Fellowship in Cognitive Neuroscience from University of New Mexico, and a BA from University of Massachusetts Amherst in Psychology, Dr. Lieberman’s research and research leadership experience ranges from genetics to learning theory, animal behavior to artificial intelligence, and human variability to team dynamics; with additional expertise in S&T strategy and the opportunities afforded by the Future of Work. Specific areas of Dr. Lieberman’s technical expertise include maximizing human potential, human-autonomy teaming; neuroanatomical organization and connectivity; brain structure-function coupling; learning-driven neuroplasticity; non-invasive neurostimulation and cognitive enhancement; neuroimaging; mind-body medicine and mindfulness meditation; and the mechanisms of neurodegenerative disease, neuropathology, and brain injury.

Angel Eduardo (http://angeleduardo.com/) is a writer, musician, photographer, and designer based in New York City, who serves an Advisory Board member, FAIR in the Arts Fellow, and Director of Messaging & Editorial for the Foundation Against Intolerance & Racism (FAIR - https://www.fairforall.org/), where he helps shape the organization's pro-human approach to our often contentious and divided discourse. He is also a contributor to the Center for Inquiry’s blog, where he writes on science, communication, skepticism, and morality for a column entitled Searching for Better Angels, and is best-known for coining and promoting the rhetorical concept of star-manning. Angel holds a Master of Fine Arts in Creative Writing from CUNY Hunter College, and has had writing featured in Newsweek, Areo Magazine, Mr. Beller’s Neighborhood, and The Caribbean Writer, among other print and online publications. Angel's photographs have been featured in various exhibitions and used as cover art for books—most notably in Personal Effects: Essays on Memoir, Teaching and Culture in the Work of Louise DeSalvo for Fordham University Press, which makes use of his photograph, “Early Bird.” Angel has been writing, performing, and recording music since the age of 15, and has been intimately involved in every creative facet of his projects, from songwriting, producing, mixing, and mastering, to designing and overseeing the creation of album artwork, concert posters, and merchandise. Be it with music, writing, photography, or design, Angel is an artist inspired to inspire. His hope is to pay it forward—providing others with the same solace, inspiration, perspective, and opportunity for personal and intellectual growth that the work of others has done for him. In the social realm, Angel advocates for a compassionate, honest, and civil approach to discourse, even when we’re incentivized to bare our teeth and dig in our heels. Through his work he hopes to foster more productive conversations on the topics of the day, all bolstered by his own six words of advice: Be kind; we’re all first drafts.

Dr. Brad Stanfield, MD (https://drstanfield.com/) is a general medical practitioner from Auckland, New Zealand, as well as the host of the rapidly growing Extend Healthspan channel (https://www.youtube.com/channel/UCpcvPcHJVOkO9Qp79BOagTg) on YouTube. Dr. Stanfield graduated in 2015 from the University of Auckland, New Zealand with his MD, worked in hospital medicine for several years, including a role as an orthopedic registrar, before moving into general community practice focusing on healthspan-centric medicine.

Short from @Progress, Potential, and Possibilities - https://www.youtube.com/watch?v=3BVRLLYocP8

Short from @Progress, Potential, and Possibilities - https://www.youtube.com/watch?v=2MMJPjnShZs&t=1s

Short from @Progress, Potential, and Possibilities - https://www.youtube.com/watch?v=Ip5Sr9MrsWg